Skip to content

Drug interactions

Eliglustat + Octreotide

Severity: Moderate

Eliglustat and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so using them together may add to the risk of ventricular arrhythmias, including torsades de pointes. Octreotide-related bradycardia may worsen this risk. Eliglustat exposure is also raised in patients with reduced CYP2D6 activity or taking CYP inhibitors, which increases the concern.

What this interaction means in plain words

Eliglustat and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eliglustat belongs to Miscellaneous; Octreotide belongs to Endocrine.

Evidence level: Low

Why it happens

Additive QT interval prolongation through pharmacodynamic effects on cardiac repolarization.

What to do

Obtain a baseline ECG and correct potassium and magnesium before combining. Monitor ECG and heart rate during therapy, and reassess the combination if QTc lengthens substantially.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Octreotide?

MediHelp rates the interaction as moderate. Eliglustat and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, so using them together may add to the risk of ventricular arrhythmias, including torsades de pointes. Octreotide-related bradycardia may worsen this risk. Eliglustat exposure is also raised in patients with reduced CYP2D6 activity or taking CYP inhibitors, which increases the concern.

How serious is the interaction between Eliglustat and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium before combining. Monitor ECG and heart rate during therapy, and reassess the combination if QTc lengthens substantially.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in